End-Stage Renal Disease: Clinical Trials

37 trials for End-Stage Renal Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

29 completed, 3 unknown, 2 not yet recruiting, 1 recruiting. 37 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 437Completed 29, Unknown 3, Not yet recruiting 2, Recruiting 1, Terminated 1, Withdrawn 1

Follow End-Stage Renal Disease: new trials by email Literature Review of End-Stage Renal Disease trials Research Report on End-Stage Renal Disease

Trials (filtered) newest first · largest first

All 37 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study on the Safety and Efficacy of a Time-of-Day-Based Individualized Tacrolimus Dosing Regimen in Kidney Transplant Recipients
Chronotherapy-based individualized low-morning high-evening tacrolimus dosing, conventional dosing regimen - End-Stage Renal Disease
Phase 4Not yet recruitingThe First Affiliated Hospital of Guangzhou Medical University1002026-10-252026-10-16
Levocarnitine for Reducing ESA Requirements in Hemodialysis Patients With Renal Anemia
Levocarnitine Injection, Usual ESA-Based Anemia Care - Anemia, Kidney Failure
Phase 4Not yet recruitingShaikh Zayed Hospital, Lahore942025-09-152025-09-12
Fexofenadine Versus Gabapentin for Uremic Pruritus in Patients on Regular Hemodialysis
Fexofenadine, Gabapentin - Uremic Pruritus, Chronic Kidney Disease-associated Pruritus
Phase 4CompletedTanta University602024-07-012025-04-27
Pharmacokinetics and Dialyzability of Dapagliflozin in Dialysis Patients
Dapagliflozin 10Mg Tab - End-stage Renal Disease
Phase 4CompletedUniversity of Campinas, Brazil52022-04-252023-03-09
Channa Striatus Extract on Albumin and Hs-CRP ESRD
Channa Striatus extract, Maltodextrin - End-Stage Renal Disease, Inflammation
Phase 4CompletedUniversitas Sebelas Maret402021-01-012022-11-14
The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
Warfarin - Atrial Fibrillation and Flutter, Stroke
Phase 4RecruitingNicholas Carlson7182019-10-092026-05-19
Ombitasvir/ Paritaprevir / Ritonavir Plus Ribavirin in Management HCV and End-stage Kidney Disease
Ombitasvir / Paritaprevir / Ritonavir /Ribavirin Oral Tablet - End-stage Renal Disease, HCV Coinfection
Phase 4CompletedAssiut University1102018-05-012020-01-10
Pilot: Insulin Sensitivity/Management in Hyperglycemic Patients in Perioperative Period ESRD/Non-ESRD
IV Novolin R human insulin - End-Stage Renal Disease, Diabetes Mellitus
Phase 4TerminatedState University of New York - Downstate Medical Center402018-05-012020-10-26
A Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney Transplant
Rabbit Anti-thymocyte Immunoglobulin, Tacrolimus, Methylprednisolone - End-stage Renal Disease
Phase 4CompletedSanofi1152017-08-162022-04-25
Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis
Ferric Citrate - Kidney Failure, Chronic, End-stage Renal Disease
Phase 4CompletedPanion & BF Biotech Inc.2022017-04-122020-01-13
Exploring Renal Transplants Using Hepatitis C Infected Donors for HCV-negative Recipients
Zepatier, Ribavirin, Sofosbuvir - End-Stage Renal Disease, Hepatitis C
Phase 4CompletedJohns Hopkins University102016-07-202018-09-06
Apixaban in Hemodialysis
apixaban - End-stage Renal Disease
Phase 4CompletedJewish General Hospital72016-04-012016-08-30
Sup-Icu RENal (SIREN)
Pantoprazole, Saline 0.9% (matching placebo) - Critical Illness, Acute Kidney Injury
Phase 4CompletedInsel Gruppe AG, University Hospital Bern33502016-02-012018-09-11
Effects of Oral Sodium Bicarbonate Supplementation in Haemodialysis Patients (BicHD)
sodium bicarbonate 500mg capsules - End-stage Renal Disease
Phase 4CompletedImperial College Healthcare NHS Trust442015-11-012016-10-03
Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5
Telavancin, Pharmacokinetic Blood Sampling - End-Stage Renal Disease, Stage 5 Chronic Kidney Disease
Phase 4CompletedUniversity of Michigan82015-07-012017-04-04
Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients
Clopidogrel first, Ticagrelor first - Acute Coronary Syndrome, Chronic Kidney Disease
Phase 4UnknownPing-Yen Liu802014-01-012015-06-02
Comparison of Cardiac Index and Cardiac Output Effect During Maintenance Hemodialysis Between Acetate-Free and Acetate-Based Online Hemodiafiltration
Acetate-free dialysis solution - End-stage Renal Disease
Phase 4CompletedChulalongkorn University222012-10-012013-02-15
Comparison of a TauroLock™ Based Regimen to 4% Citrate as Lock Solution in Tunneled Haemodialysis Catheters for the Prevention of Bacteraemia and Dysfunction
4% citrate lock solution regimen, TauroLock lock solution regimen - Catheter Infections, End-stage Renal Disease
Phase 4CompletedMedical University of Vienna1062012-01-012016-12-05
Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients
Ranolazine, Pharmacokinetic Blood and Dialysate Sampling, QT Interval - End-stage Renal Disease, Cardiovascular Disease
Phase 4CompletedUniversity of Michigan172011-10-012017-10-16
Liraglutide Treatment to Patients With Severe Renal Insufficiency
Liraglutide - Type 2 Diabetes Mellitus, End-stage Renal Disease
Phase 4CompletedBo Feldt-Rasmussen402011-09-012013-10-09

Showing 20 of 37. Sign in to see all of them.

Narrower conditions

Kidney Failure, Chronic (37)  ·  Inflammation (5)  ·  Cardiovascular Diseases (3)  ·  Hypertrophy, Left Ventricular (3)  ·  Renal Insufficiency, Chronic (3)  ·  Anemia (2)  ·  Atherosclerosis (2)  ·  Renal Insufficiency (2)  ·  Acidosis (1)  ·  Acute Coronary Syndrome (1)  ·  Acute Kidney Injury (1)  ·  Arrhythmias, Cardiac (1)  ·  Atrial Fibrillation (1)  ·  Critical Illness (1)  ·  Diabetes Mellitus (1)

Broader conditions

Chronic Disease (37)  ·  Disease Attributes (37)  ·  Female Urogenital Diseases (37)  ·  Female Urogenital Diseases and Pregnancy Complications (37)  ·  Male Urogenital Diseases (37)  ·  Pathologic Processes (37)  ·  Pathological Conditions, Signs and Symptoms (37)  ·  Urogenital Diseases (37)  ·  Kidney Diseases (36)  ·  Urologic Diseases (36)  ·  Renal Insufficiency (35)  ·  Renal Insufficiency, Chronic (34)  ·  Cardiovascular Diseases (6)  ·  Heart Diseases (6)  ·  Nutritional and Metabolic Diseases (5)

Interventions

Antilymphocyte Serum (2)  ·  Mycophenolic Acid (2)  ·  Ribavirin (2)  ·  Starch (2)  ·  Tacrolimus (2)  ·  thymoglobulin (2)  ·  Acetylcysteine (1)  ·  Alendronate (1)  ·  Ammonium Chloride (1)  ·  Aspirin (1)  ·  Captopril (1)  ·  Carnitine (1)  ·  Citric Acid (1)  ·  Daclizumab (1)  ·  Dialysis Solutions (1)

Sponsors

Ege University (3)  ·  Coordinación de Investigación en Salud, Mexico (2)  ·  National Taiwan University Hospital (2)  ·  University of Michigan (2)  ·  Assiut University (1)  ·  Bo Feldt-Rasmussen (1)  ·  Chulalongkorn University (1)  ·  Eisai Co., Ltd. (1)  ·  Ercan OK (1)  ·  Far Eastern Memorial Hospital (1)  ·  Imperial College Healthcare NHS Trust (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  Jewish General Hospital (1)  ·  Johns Hopkins University (1)  ·  Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (1)

Countries

United States (7)  ·  Taiwan (5)  ·  Turkey (Türkiye) (4)  ·  China (3)  ·  Denmark (3)  ·  Egypt (2)  ·  Mexico (2)  ·  Austria (1)  ·  Brazil (1)  ·  Canada (1)  ·  Hong Kong (1)  ·  Indonesia (1)  ·  Japan (1)  ·  Kazakhstan (1)  ·  Switzerland (1)

Top investigators

Alfonso M. M Cueto-Manzano, MD, MSc, PhD (2)  ·  Ercan Ok, M.D (2)  ·  Ercan Ok, MD (2)  ·  Ahmed M Hussein, PhD (1)  ·  Angela YM Wang, MD, PhD, FRCP (1)  ·  Anne-Lise Kamper, MD DMSc (1)  ·  Bo Feldt-Rasmussen, Prof, DMSc (1)  ·  Bruce A Mueller, PharmD (1)  ·  Bruce A. Mueller, PharmD (1)  ·  Christian D Peters, MD PhD (1)  ·  Christian Torp-Pedersen, Prof MD DMSc (1)  ·  Damien Ashby, PhD, MRCP (1)  ·  Der-Cherng Tarng, MD, PhD (1)  ·  Ditte Hansen, MD PhD (1)

Results publications

PMID 35224730, PMID 18497677, PMID 19714613, PMID 19846545, PMID 21401720, PMID 22172590, PMID 23624993, PMID 25079862, PMID 25083614, PMID 26283739, PMID 26465152, PMID 29321041, PMID 29507971, PMID 30909832, PMID 31480045, PMID 34231877, PMID 34613416, PMID 35239732, PMID 37227937, PMID 37526194, PMID 38413147, PMID 39963952

NIH funding

2018 (1)